Are Some Anticoagulants More Equal Than Others? - Evaluating the Role of Novel Oral Anticoagulants in AF Ablation

By  

Current Cardiology Reviews, Vol. 12, Iss. 4, 2016-11 ,pp. : 330-335

Bentham Science Publishers

Access to resources Recommend Favorite

Novel oral Anticoagulants in Non-Valvular Atrial Fibrillation

By  

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol. 12, Iss. 1, 2014-04 ,pp. : 3-8

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Oral Anticoagulants in Atrial Fibrillation: Update on Apixaban

By  

Current Cardiology Reviews, Vol. 13, Iss. 1, 2016-11 ,pp. : 41-46

Bentham Science Publishers

Access to resources Recommend Favorite

Are we at the Goal Line with the Novel Oral Anticoagulants and Have We Reached the End of the Line for Dronedarone and Vernakalant – or is There More to Come?

By  

Current Cardiology Reviews, Vol. 10, Iss. 4, 2014-11 ,pp. : 315-316

Bentham Science Publishers

Access to resources Recommend Favorite

New oral anticoagulants

By Galanis Taki   Thomson Lynda   Palladino Michael   Merli Geno  

Journal of Thrombosis and Thrombolysis, Vol. 31, Iss. 3, 2011-04 ,pp. : 310-320

Springer Publishing Company

Access to resources Recommend Favorite